PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Barreto, Andrew D.
TI  - Combination Full-Dose IV-tPA + Argatroban is Safe and May Result in Higher Rates of Recanalization
DP  - 2011 Apr 01
TA  - MD Conference Express
PG  - 17--18
VI  - 11
IP  - 1
4099  - http://mdc.sagepub.com/content/11/1/17.2.short
4100  - http://mdc.sagepub.com/content/11/1/17.2.full
AB  - Argatroban is a direct thrombin inhibitor that safely augments the benefit of tPA in animal stroke models; however, human data are limited. The Argatroban tPA Stroke Study [ARTSS; NCT00268762] is a multicenter, Phase II, prospective, open-label, safety and activity study of argatroban and tPA in patients with ischemic stroke.